PLUR Pluri Inc Total Asset Value of Company

PLUR (pluri-biotech.com) - company brandmark

This market valuation chart for Pluri Inc. (PLUR), whose total assets amount to 31.78, reflects the business dynamics of its metabolism-focused drug development. The brand's positive image is driven by an innovative cell cultivation system. Financial success relies on the implementation of placental therapy and the development of synthetic meat, while global instability and trade restrictions hinder raw material logistics and the execution of international trials.

PLUR (Pluri) Company Total Assets history from 04/28/2023 to 10/29/2026
Manufactured products of Pluristem Therapeutics

The development of Pluri Inc. (PLUR) in the field of cell therapy through alliances with the public sector and agribusiness requires significant resources, the volume of which GURU.Markets determines inversely via return on assets (ROA). This level of consolidated assets reflects the total value of property and liabilities, where base growth without a proportional increase in profit signals capital management efficiency and risks of liquidity freezes.

Key competitors